• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

drug approvals

Food and Drug Administration
Pharma

Regulatory tracker: FDA signs off on Incyte's Jakafi XR

Here, we're tracking the regulatory progress of in-market products, including expansions into key geographies and new indications.
Angus Liu , Eric Sagonowsky , Fraiser Kansteiner , Kevin Dunleavy , Zoey Becker May 4, 2026 2:56pm
A photo finish at a horse race with both horses crossing the finish line

Pfizer, Arvinas' breast cancer med wins FDA approval

May 1, 2026 3:50pm
FDA

FDA approves leucovorin without clinical trial—but not for autism

Mar 10, 2026 9:00am
Blue background with pill pattern with the words The Top Line

Drug approvals went from crawl to sprint in 2025

Jan 16, 2026 10:00am
FDA

2025 approvals: Biopharma delivered 55 new drugs, biologics

Jan 5, 2026 3:00am
two green lights

Vanda, Agios score holiday season FDA approvals

Jan 2, 2026 11:33am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings